1 Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Report.
www.goldcopd.org.
2 Herth FJF, Slebos DJ, Rabe KF, Shah PL. Endoscopic Lung Volume Reduction: An Expert Panel Recommendation. Respiration. 2016;91:241–50.
3 Matthys H, Seeger W, editors. Klinische Pneumologie. 4th ed. Heidelberg: Springer; 2008.
4 Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax. 2008;63:761–7.
5 McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567–75.
6 Van Geffen WH, Kerstjens HAM, Slebos DJ. Emerging bronchoscopic treatments for chronic obstructive pulmonary disease. Pharmacol Ther. 2017;S0163-7258(17)30126-2.
doi: 10.1016/j.pharmthera.2017.05.007. [Epub ahead of print].
7 Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. National Emphysema Treatment Trial Research Group. N Engl J Med. 2003;348(21):2059–73.